Oncology Medical News about organ-confined renal cell carcinoma;overwieght;improvedcancer-specific survival

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma
Journal of Cancer Research & Clinical Oncology, 06/24/09

Schrader AJ et al. - In a study to assess whether different body mass index (BMI) levels at the time of surgery had an effect on long-term prognosis of renal cell carcinoma (RCC) pts, being overweight was identified as an independent prognostic marker of improved tumor-specific survival in pts with organ-confined RCC.

Methods

771 pts, with complete information about their BMI, who had undergone renal surgery for RCC were evaluated.
Mean follow-up was 5.48 yrs.

Results

Underweight, normal weight, pre-obesity, and obesity were diagnosed in 4 (0.5%), 239 (31%), 356 (46.2%), and 172 (22.3%) RCC pts, respectively.
Overweight (BMI >25) was significantly associated with younger age and positive nodal status, but not with tumor stage, grade, visceral metastasis, gender, histological subtype, or tumor-related symptoms.
Overweight pts had a significantly lower risk of cancer-related death; their median 5-yr tumor-specific survival rate was 80% vs 72% for pts with a BMI <25.
Subgroup analysis revealed that the positive association between overweight and survival was even more pronounced in organ-confined RCC, but no correlation was observed in advanced disease.